Curcusone D, a novel ubiquitin–proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth-Reference-Cited by-同舟云学术

Curcusone D, a novel ubiquitin–proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth

Published:2014-06 Issue:6 Volume:1840 Page:2004-2013
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Cao Mei-Na,Zhou Yu-Bo,Gao An-Hui,Cao Jia-Yi,Gao Li-Xin,Sheng Li,Xu Lei,Su Ming-Bo,Cao Xian-Chao,Han Meng-meng,Wang Ming-Kui,Li Jia

Funder

National Natural Science Foundation of China

National Science and Technology Major Projects for “Major New Drugs Innovation and Development”

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference47 articles.

1. Proteasome inhibitors in multiple myeloma: 10years later;Moreau;Blood,2012

2. Carfilzomib: a second-generation proteasome inhibitor for the treatment of relapsed and refractory multiple myeloma;Thompson;Ann. Pharmacother.,2013

3. The ubiquitin–proteasome proteolytic pathway: destruction for the sake of construction;Glickman;Physiol. Rev.,2002

4. The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma;Xu;Blood,2010

5. Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of bortezomib/proteasome inhibitor PS-341;Chauhan;Oncogene,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

2. Unveiling poly(rC)-binding protein 2 as the target protein for curcusone C against prostate cancer: mechanism validation through click chemistry-activity based proteomics profiling approach;BMC Cancer;2023-10-09

3. The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment;Pharmacology & Therapeutics;2022-12

4. Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma;Antioxidants;2022-02-25

5. Redox regulation of DUBs and its therapeutic implications in cancer;Redox Biology;2021-12